×
Search your requirement
Search your requirement
Home
Press Releases
Submit Release
Events
Reach Us
Social media
Search
Home
Press Releases
Submit Release
Events
Reach Us
Search
MilliporeSigma receives the industry's first EXCiPACT certification for cell culture media manufacturing
Ibex Medical Analytics achieves notable milestones with its AI-first approach to cancer diagnostics
Albertsons Companies pharmacies now offer COVID and flu vaccines to help protect communities this respiratory virus season
OmniSYS rebrands as XiFin Pharmacy Solutions, launches Pharmacy Payor Rate Transparency Monitor, and earns the Pharmacy 500 Award
Gilead’s Livdelzi (Seladelpar) receives FDA accelerated approval for primary biliary cholangitis
ProJenX announces the formation of its Clinical Advisory Board
Citius Pharmaceuticals' LYMPHIR™ wins FDA approval for relapsed/refractory cutaneous T-cell lymphoma
NewAmsterdam Pharma announces positive topline data from the Phase 3 BROOKLYN trial of Obicetrapib in heterozygous familial hypercholesterolemia patients
Cygnus Technologies and TriLink BioTechnologies® collaborate to launch AccuRes™ Host Cell DNA Quantification Kits
Neurocrine Biosciences Launches INGREZZA® SPRINKLE (valbenazine) Capsules.
Updated flu and COVID-19 vaccinations are now available at CVS Pharmacy® and MinuteClinic
FDA Grants Second Approval for EPKINLY® (epcoritamab-bysp) to Treat Relapsed or Refractory Follicular Lymphoma
Featured Press Releases
Tetra Pharm Technologies advances CB1 antagonist, TPT0701, for appetite suppression into preclinical testing
Eden Expands Access to Glutathione Injection Protocols via Independent Licensed Providers and Pharmacies
21 May 2025
Eden, the leading health platform connecting individuals with licensed providers and pharmacies
...
Octapharma USA: FDA Grants Orphan Drug Exclusivity to wilate®
Hyalex Orthopaedics Reports Treatment of First Patients with Novel HYALEX® Knee Cartilage System
Great Bay Bio launches its Intelligent Drug Development Ecosystem
NLS Pharmaceutics and Kadimastem announce a $500,000 initial closing of a $1 million fundraising, with shares priced at $3.10, a 48% premium over the January 6, 2025 market price
Setting a New Standard for End-to-End Traceability and Data Integrity, Waters Enhances Alliance iS HPLC System Software.
By
Waters Corporation
Waters Corporation
18 Jun 2025
Enhancing Preclinical Research Support, SoBran, Inc. Expands BioScience Services to Los Angeles
By
SoBran, Inc.
SoBran, Inc.
18 Jun 2025
Space Cargo Unlimited and Exobiosphere Partner for High-Throughput Space Biotech
By
Space Cargo Unlimited; Exobiosphere
Space Cargo Unlimited; Exobiosphere
17 Jun 2025
Boehringer Ingelheim and the Lung Cancer Research Foundation Announce New Research Collaboration
By
LUNG CANCER RESEARCH FOUNDATION (
LUNG CANCER RESEARCH FOUNDATION (
17 Jun 2025
Dupixent® outperformed Xolair® in treating CRSwNP with asthma in the first Phase 4 head-to-head trial
By
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
16 Jun 2025
To Target the Multi-Billion Dollar Kidney Disease Market, Mezzion Expands Its Udenafil Pipeline to ADPKD
By
Mezzion Pharmaceuticals, Inc
Mezzion Pharmaceuticals, Inc
16 Jun 2025
Log in
Username
Show
Remember Me
Log in
Create an account
Forgot your username?
Forgot your password?
Pharmaceutical
Precision In Clinical Trials Summit Zurich Europe 2025
01 Jul 2025
10:00 am
- 02 Jul 2025
5:30 pm
Switzerland
Pharmaceutical
Australia Regulatory Device Summit 2025
17 Jul 2025
10:00 am
- 18 Jul 2025
5:30 pm
Australia
Pharmaceutical
Precision In Clinical Trials Summit Zurich Europe 2025
01 Jul 2025
10:00 am
- 02 Jul 2025
5:30 pm
Switzerland
Pharmaceutical
Australia Regulatory Device Summit 2025
17 Jul 2025
10:00 am
- 18 Jul 2025
5:30 pm
Australia
Pharmaceutical
Precision In Clinical Trials Summit Zurich Europe 2025
01 Jul 2025
10:00 am
- 02 Jul 2025
5:30 pm
Switzerland
Pharmaceutical
Australia Regulatory Device Summit 2025
17 Jul 2025
10:00 am
- 18 Jul 2025
5:30 pm
Australia
Most Popular
MM+M honors Petauri's Nicole Lodowski as a 2025 40 Under 40 awardee
By
Petauri
Dec 11
Avenacy Enters U.S. Market with Launch of Doxycycline for Injection, USP
By
Avenacy
May 27
ViroCell Biologics Signs Master Services Agreement With Prominent NCI-Designated Cancer Center
By
ViroCell Biologics
Jul 23
June
2025
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
User Area
Login page
Registration
Edit Profile
Forgot Password
Discover
About Us
Terms Of Use
Privacy Policy
FAQs
Engage with Us
Search on Site
Post Press Release
Promote Brand
List Your Event
Subscribe for e-Newsletter Monthly
Subscribe to the Pharmaceutical Era newsletter to receive timely updates from your favorite products.
Email
I consent to subscribing to the selected email lists.
Enter the code below
Subscribe
1
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies. To find out more, please click
here
.
I understand